ID SKH1 [Human leukemia] AC CVCL_C124 SY SKH-1 DR Cosmic; 919117 DR Cosmic; 947370 DR Cosmic; 1012118 DR Wikidata; Q54954739 RX DOI=10.1016/B978-0-12-221970-2.50457-5; RX PubMed=8313895; RX PubMed=9510473; RX PubMed=10576511; RX PubMed=15156182; RX PubMed=16408098; CC Population: Japanese. CC Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=8313895; PubMed=10576511). DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive DI ORDO; Orphanet_521; Chronic myeloid leukemia OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Sex unspecified AG Age unspecified CA Cancer cell line DT Created: 06-06-12; Last updated: 19-12-24; Version: 14 // RX DOI=10.1016/B978-0-12-221970-2.50457-5; RA Drexler H.G.; RT "The leukemia-lymphoma cell line factsbook."; RL (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001). // RX PubMed=8313895; DOI=10.1002/j.1460-2075.1994.tb06288.x; PMCID=PMC394839; RA Mitani K., Ogawa S., Tanaka T.U., Miyoshi H., Kurokawa M., Mano H., RA Yazaki Y., Ohki M., Hirai H.; RT "Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) RT causes blastic crisis in chronic myelocytic leukemia."; RL EMBO J. 13:504-510(1994). // RX PubMed=9510473; DOI=10.1111/j.1349-7006.1998.tb00476.x; PMCID=PMC5921588; RA Hosoya N., Hangaishi A., Ogawa S., Miyagawa K., Mitani K., Yazaki Y., RA Hirai H.; RT "Frameshift mutations of the hMSH6 gene in human leukemia cell RT lines."; RL Jpn. J. Cancer Res. 89:33-39(1998). // RX PubMed=10576511; DOI=10.1016/S0145-2126(99)00131-9; RA Uphoff C.C., Habig S., Fombonne S., Matsuo Y., Drexler H.G.; RT "ABL-BCR expression in BCR-ABL-positive human leukemia cell lines."; RL Leuk. Res. 23:1055-1060(1999). // RX PubMed=15156182; DOI=10.1038/sj.onc.1207777; RA Mitani K.; RT "Molecular mechanisms of leukemogenesis by AML1/EVI-1."; RL Oncogene 23:4263-4269(2004). // RX PubMed=16408098; DOI=10.1038/sj.leu.2404081; RA Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.; RT "JAK2 V617F tyrosine kinase mutation in cell lines derived from RT myeloproliferative disorders."; RL Leukemia 20:471-476(2006). //